Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Family Lifestyles, Actions, and Risk Education Intervention: Version 2
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
LITT and Pembrolizumab in Recurrent Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Polish Microbiome Map
- Status
- UNKNOWN
- Phase
- N/A
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia
- Status
- COMPLETED
- Phase
- N/A
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
- Status
- COMPLETED
- Phase
- N/A
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
- Status
- UNKNOWN
- Phase
- N/A
PVSRIPO in Combination With Nivolumab in Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1